FIRESTONE LEIGH H has a total of 15 patent applications. Its first patent ever was published in 2007. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals and medical technology are SOLARTIUM ENTPR LTD, CONTROL DELIVERY SYS INC and GLYCOGENESYS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Object sterilising | |
#4 | Implantable devices |
# | Name | Total Patents |
---|---|---|
#1 | Firestone Leigh H | 15 |
#2 | Matheny Robert G | 1 |
Publication | Filing date | Title |
---|---|---|
WO2009073788A1 | Compositions and methods for treating menopausal females | |
US2008095860A1 | Extracellular matrix to treat malignancy | |
US2008254139A1 | Methods and compositions to treat ovarian cancer | |
US2008260853A1 | Extracellular matrix as surgical adjunct in a lumpectomy procedure | |
US2008279939A1 | Extracellular matrix compositions for tissue regeneration | |
US2008281418A1 | Breast implant articles of multi-layered sheets of extracellular matrix or balled strips and pieces of extracellular matrix | |
US2007196380A1 | Extracellular matrix to treat malignancy in mammals |